VEGF Signaling Pathway Germline Polymorphisms as Prognostic Pharmacogenetic Biomarkers in Localized High-Grade Osteosarcoma Patients from the GEIS-33 Protocol.

Saved in:
Bibliographic Details
Title: VEGF Signaling Pathway Germline Polymorphisms as Prognostic Pharmacogenetic Biomarkers in Localized High-Grade Osteosarcoma Patients from the GEIS-33 Protocol.
Authors: Salazar, Juliana1 (AUTHOR), Arranz, María J.2 (AUTHOR), Martin-Broto, Javier3 (AUTHOR), Serra, Massimo4 (AUTHOR), Palmerini, Emanuela4,5 (AUTHOR), Martínez-García, Jeronimo6 (AUTHOR), Juan-Ribelles, Antonio7 (AUTHOR), Andion, Maitane8 (AUTHOR), Martinez-Trufero, Javier9 (AUTHOR), Gutiérrez, Guiomar10 (AUTHOR), Echebarria-Barona, Aizpea11 (AUTHOR), Vaz-Salgado, Maria A.12 (AUTHOR), Regueiro, Alexandra13 (AUTHOR), Alvarez, Rosa14 (AUTHOR), Valverde, Claudia15 (AUTHOR), Luna, Pablo16 (AUTHOR), Blay, Pilar17 (AUTHOR), Sebio, Ana1,18 (AUTHOR)
Source: Pharmaceuticals (14248247). Dec2025, Vol. 18 Issue 12, p1855. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14248247
DOI:10.3390/ph18121855